WAY-328127 is an active molecule, exhibiting an inhibitory effect on the (11β-hydroxysteroid dehydrogenase type 1) [(11β-HSD1)] enzyme. This modulation potentially leads to therapeutic applications in metabolic disorders, including (type 2 diabetes) [(T2D)] and metabolic syndrome. Its action in selectively downregulating (11β-HSD1) in adipose tissue suggests a favourable profile for addressing hyperglycemia and dyslipidemia.